Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Trial of Leflunomide in Patients With CD30+ Lymphoproliferative Disorders

NCT04463615 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT04463615
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04463615 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Trial of Leflunomide in Patients With CD30+ Lymphoproliferative Disorders
Lead sponsor
City of Hope Medical Center
Phase
Phase 2
Overall status
Completed
Start date
May 5, 2021
Completion date
July 28, 2021
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent lymphoproliferative disorder, refractory lymphoproliferative disorder